ANGION BIOMEDICA CORP. is a biopharmaceutical company based in Uniondale, New York. Their work involves discovering and developing novel therapeutic agents for acute and chronic organ injuries with an initial focus on nephrology.  Angion’s therapeutic programs modulate the natural protective, reparative, and regenerative pathways of the body in both orphan diseases and larger clinical indications.  The Company’s pre-clinical and clinical portfolio targets areas of high unmet need across a spectrum of therapeutic indications, including acute kidney injury and chronic kidney disease.